Prosthetic valve thrombosis: A regimen of treatment with low-dose and longer-course using recombinant tissue-type plasminogen activator is a promising protocol

被引：1
|
作者：
Manuel Caceres-Loriga, Fidel [1 ]
Perez-Lopez, Horacio [1 ]
Morlans-Hernandes, Karel [1 ]
机构：
[1] Inst Cardiol & Cardiovasc Surg, Havana, Cuba
来源：
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY | 2008年 / 136卷 / 04期
关键词：
D O I：
10.1016/j.jtcvs.2008.03.070
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1104 / 1105
页数：5
相关论文
共 50 条
  • [41] Fibrinolytic treatment using recombinant tissue-type plasminogen activator (rt-PA) for staphylococcal infective endocarditis
    Takigawa, Tomoya
    Miyahara, Satoshi
    Ishii, Hiromu
    Ogawa, Midori
    Fukuda, Kazumasa
    Nishimura, Yosuke
    Saito, Mitsumasa
    MICROBIAL PATHOGENESIS, 2024, 197
  • [42] THROMBOLYTIC THERAPY WITH RECOMBINANT TISSUE-TYPE PLASMINOGEN-ACTIVATOR (RT-PA) FOR THROMBOSIS OF A TRICUSPID-VALVE PROSTHESIS DURING PREGNANCY
    AZZANO, O
    FRENCH, P
    ROBIN, J
    QUINSON, P
    DELABOURDONNAYE, T
    CHAMPSAUR, G
    MELLIER, G
    NORMAND, J
    BOZIO, A
    ARCHIVES DES MALADIES DU COEUR ET DES VAISSEAUX, 1995, 88 (02): : 267 - 270
  • [43] LOW-DOSE RECOMBINANT TISSUE-TYPE PLASMINOGEN ACTIVATOR (RT-PA) THROMBOLYSIS AND ORAL FACTOR XA INHIBITOR AS ADJUNCTIVE TREATMENT IN HIGH-RISK PULMONARY EMBOLISM (PE)
    Jimenez Franco, Vicente
    Gildardo Paredes-Vazquez, Jose
    Ibarra, Marcos
    Sanchez-Diaz, Carlos
    Valdes, Felipe
    Azpiri, Hernan
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 2449 - 2449
  • [44] Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States A Doubling of Treatment Rates Over the Course of 5 Years
    Adeoye, Opeolu
    Hornung, Richard
    Khatri, Pooja
    Kleindorfer, Dawn
    STROKE, 2011, 42 (07) : 1952 - 1955
  • [45] Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke-Full Dose Regimen Stroke Trial
    Adeoye, Opeolu
    Sucharew, Heidi
    Khoury, Jane
    Vagal, Achala
    Schmit, Pamela A.
    Ewing, Irene
    Levine, Steven R.
    Demel, Stacie
    Eckerle, Bryan
    Katz, Brian
    Kleindorfer, Dawn
    Stettler, Brian
    Woo, Daniel
    Khatri, Pooja
    Broderick, Joseph P.
    Pancioli, Arthur M.
    STROKE, 2015, 46 (09) : 2529 - 2533
  • [46] LOCAL THROMBOLYSIS OF PERIPHERAL ARTERIAL OCCLUSIONS BY INFILTRATION TECHNIQUE USING LOW-DOSE RECOMBINANT TISSUE PLASMINOGEN-ACTIVATOR
    FISCHER, M
    BEER, D
    VONWRANGELL, U
    MEDIZINISCHE KLINIK, 1992, 87 (11) : 563 - 566
  • [47] Preceding thrombolysis with low-dose mutant tissue-type plasminogen activator followed by coronary angioplasty in acute myocardial infarction: PLANET trial
    Tsurumi, Yukio
    Ishii, Yasuhiro
    Ogawa, Hiroshi
    Koyanagi, Ryo
    Hagiwara, Nobuhisa
    Kasanuki, Hiroshi
    CIRCULATION, 2006, 114 (18) : 598 - 598
  • [48] Visual outcome after treatment with low-dose recombinant tissue plasminogen activator or hemodilution in ischemic central retinal vein occlusion
    Hattenbach, LO
    Wellermann, G
    Steinkamp, GWK
    Scharrer, I
    Koch, FHJ
    Ohrloff, C
    OPHTHALMOLOGICA, 1999, 213 (06) : 360 - 366
  • [49] Low dose infusion of recombinant tissue-type plasminogen activator in healthy volunteers to investigate the biodistribution of t-PA in the early phase of infusion
    vanGriensven, JMT
    Huisman, LGM
    Schoemaker, HC
    Kluft, C
    Cohen, AF
    FIBRINOLYSIS & PROTEOLYSIS, 1997, 11 (01): : 21 - 27
  • [50] Intravenous thrombolysis in stroke patients taking novel oral anticoagulants: experience with the low-dose 0.6 mg/kg of recombinant tissue-type plasminogen activator. Case reports
    Plastino, Massimiliano
    Bosco, Domenico
    Giofre, Laura
    Cristiano, Dario
    Galati, Franco
    Postorino, Paolo
    Consoli, Arturo
    Fava, Antonietta
    Consoli, Domenico
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2018, 393 : 24 - 26
12345